Netherlands· NL-37a85f1bed46

Propedix 0,5 mg/ml concentraat voor oplossing voor infusie

A alprostadil product containing alprostadil, registered in Netherlands by Oresund Pharma ApS. The same ATC class is registered in 10 of our 19 countries.

ATC C01EA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about alprostadilAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Alprostadil is registered in 10 of 19 countries.

Countries holding a registration under ATC C01EA01 (alprostadil), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search alprostadil products by name

Alprostadil · ATC C01EA01

10 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ALPROSTADIL
Manufacturer: Oresund Pharma ApS
Country: Netherlands (NL)
ATC code: C01EA01
ATC class: Alprostadil
Defined daily dose: 0.5 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
135152

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

84 interactions on record for alprostadil.

Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check alprostadil against other medicines How interaction checks work

Alprostadil · interactions on record

84 records

22 moderate
62 info

Most severe, free to view

LorcaserinA08AA11moderate
DapagliflozinA10BK01moderate
CanagliflozinA10BK02moderate
EmpagliflozinA10BK03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alprostadil in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alprostadil products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Alprestil, Alprostadil Altan
Belgium · Caverject, Caverject Impuls
Bulgaria · Алпростадил Ромфарм, Проставазин
Cyprus · Caverject, Vitaros
Czechia · Alprostan, Karon
Germany · Alprostadil Altan, Caverject
Denmark · Caverject Dual, Muse
Estonia · Muse, Neupedix
Spain · Alprostadil Altan, Alprostadil Pfizer
Finland · Caverject Dual, Muse
France · Alprostadil Intsel Chimos, Alprostadil Oresund Pharma
United Kingdom (Northern Ireland) · Alprostadil Pfizer, Caverject
Greece · Caverject, Prostin Vr
Croatia · Prostin Vr
Hungary · Alprestil, Alprostadil Altan
Ireland · Caverject, Vitaros
Iceland · Caverject Dual, Vitaros
Italy · Alprostar, Caverject
Lithuania · Muse, Neupedix
Luxembourg · Caverject, Prostavasin
Latvia · Muse, Neupedix
Malta · Caverject
Norway · Bondil, Caverject Dual
Poland · Prostavasin 60, Prostin Vr
Portugal · Caverject, Muse
Romania · Alprostadil Remedia, Alprostadil Rompharm
Sweden · Bondil, Caverject Dual
Slovenia · Alprostin Vr, Caverject
Slovakia · Alprostan, Alprostapint

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f00cf222-9ea2-4b66-aad4-2f14897b5e50
GET /v1/drugs/f00cf222-9ea2-4b66-aad4-2f14897b5e50?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h135152_smpc.pdf",
  "strength": null,
  "atc_label": "Alprostadil",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135152",
  "excipients": [
    "ETHANOL"
  ],
  "substances": [
    "ALPROSTADIL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135152.pdf",
  "authorised_at": "2025/12/15",
  "procedure_number": "AT/H/1362/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135152",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about alprostadil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console